These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20146218)

  • 1. Non-cerebellar primitive neuroectodermal tumors (PNET): summary of the Milan consensus and state of the art workshop on marrow ablative chemotherapy with hematopoietic cell rescue for malignant brain tumors of childhood and adolescents.
    Fangusaro J; Massimino M; Rutkowski S; Gururangan S
    Pediatr Blood Cancer; 2010 Apr; 54(4):638-40. PubMed ID: 20146218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors.
    Gajjar A; Pizer B
    Pediatr Blood Cancer; 2010 Apr; 54(4):649-51. PubMed ID: 20146223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
    Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
    Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
    Fangusaro J; Finlay J; Sposto R; Ji L; Saly M; Zacharoulis S; Asgharzadeh S; Abromowitch M; Olshefski R; Halpern S; Dubowy R; Comito M; Diez B; Kellie S; Hukin J; Rosenblum M; Dunkel I; Miller DC; Allen J; Gardner S
    Pediatr Blood Cancer; 2008 Feb; 50(2):312-8. PubMed ID: 17668858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival in a child with a central nervous system medulloepithelioma.
    Moftakhar P; Fan X; Hurvitz CH; Black KL; Danielpour M
    J Neurosurg Pediatr; 2008 Nov; 2(5):339-45. PubMed ID: 18976104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A consensus and state-of-the-art workshop: marrow ablative chemotherapy with hematopoietic cell rescue for malignant brain tumors of childhood and adolescence.
    Finlay JL; Massimino M
    Pediatr Blood Cancer; 2010 Apr; 54(4):634. PubMed ID: 20146221
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors.
    Finlay JL
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S1-5. PubMed ID: 8971398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of treatment failure in infants with primitive neuroectodermal tumors who were treated on CCG-921: a phase III combined modality study.
    Hong TS; Mehta MP; Boyett JM; Donahue B; Rorke LB; Zeltzer PM
    Pediatr Blood Cancer; 2005 Oct; 45(5):676-82. PubMed ID: 16007595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain magnetic resonance imaging after high-dose chemotherapy and radiotherapy for childhood brain tumors.
    Spreafico F; Gandola L; Marchianò A; Simonetti F; Poggi G; Adduci A; Clerici CA; Luksch R; Biassoni V; Meazza C; Catania S; Terenziani M; Musumeci R; Fossati-Bellani F; Massimino M
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1011-9. PubMed ID: 17904307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
    Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transverse myelitis after therapy for primitive neuroectodermal tumors.
    Ullrich NJ; Marcus K; Pomeroy SL; Turner CD; Zimmerman M; Lehmann LE; Scott RM; Goumnerova L; Gillan E; Kieran MW; Chi SN
    Pediatr Neurol; 2006 Aug; 35(2):122-5. PubMed ID: 16876009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of stem cell transplant for brain tumors.
    Gardner SL
    Pediatr Transplant; 2004 Jun; 8 Suppl 5():28-32. PubMed ID: 15125703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue.
    Fangusaro JR; Jubran RF; Allen J; Gardner S; Dunkel IJ; Rosenblum M; Atlas MP; Gonzalez-Gomez I; Miller D; Finlay JL
    Pediatr Blood Cancer; 2008 Mar; 50(3):715-7. PubMed ID: 17009232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological modification strategies following marrow ablative, high-dose chemotherapy (HDCT) with autologous hematopoietic stem cell rescue (AHSCR) for pediatric brain tumors.
    Zacharoulis S; Chi S; Kadota R; Kieran M
    Pediatr Blood Cancer; 2010 Apr; 54(4):654-6. PubMed ID: 20146216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of intensive chemotherapy in the treatment of medulloblastoma/primitive neuroectodermal tumor in children].
    Konoplia NE; Strongin IuS; Talabaev MV; Aleĭnikova OV
    Vopr Onkol; 2008; 54(2):157-63. PubMed ID: 18522163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
    Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
    Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
    Biswas S; Burke A; Cherian S; Williams D; Nicholson J; Horan G; Jefferies S; Williams M; Earl HM; Burnet NG; Hatcher H
    Pediatr Blood Cancer; 2009 Jul; 52(7):796-803. PubMed ID: 19202566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is primitive neuroectodermal tumor of the kidney a distinct entity?
    Rodriguez-Galindo C; Marina NM; Fletcher BD; Parham DM; Bodner SM; Meyer WH
    Cancer; 1997 Jun; 79(11):2243-50. PubMed ID: 9179073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive chemotherapy with stem cell support-experience in pediatric solid tumours.
    Pinkerton CR
    Bull Cancer; 1995; 82 Suppl 1():61s-65s. PubMed ID: 7626856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.